Research
Hormonal
Alpha-hydroxybutyrate (a-HB) inhibits glucose-induced insulin release, while linoleoyl-glycerophosphocholine (L-GPC) stimulates it, providing a physiological mechanism for their predictive value regarding beta-cell dysfunction.
This paper explains why these markers matter: a-HB directly suppresses insulin secretion, while L-GPC enhances it. This suggests that high a-HB and low L-GPC are not just passive signs of disease but actively contribute to beta-cell failure. However, this was shown in rat cells, so human application is theoretical.
ModerateSupportsMEDIUM confidence
When their activity was examined, a-HB inhibited and L-GPC stimulated glucose-induced insulin release in INS-1e cells.
Why this rating
In vitro study using a rat insulinoma cell line (INS-1e), not human islets.
Source
Early Metabolic Markers of the Development of Dysglycemia and Type 2 Diabetes and Their Physiological Significance
Ele Ferrannini et al. · Diabetes · 2012
DOI 10.2337/db12-0707
cohort · n=3841Cited 357×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →